Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 9/20 | 0.40 |
| ▸ | CNR1 | P21554 | 4/20 | 0.40 |
| ▸ | S1PR3 | Q99500 | 2/20 | 0.39 |
| ▸ | P2RX3 | P56373 | 6/20 | 0.38 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.37 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31203180 | 0.93 | CNR2 (0.42) | CNR2CNR1S1PR3HRH3 | |
| SCHEMBL31203184 | 0.93 | CNR2 (0.42) | CNR2CNR1S1PR3HRH3 | |
| SCHEMBL21485562 | 0.91 | S1PR3 (0.40) | CNR2CNR1S1PR3P2RX3LIPG | |
| SCHEMBL21458146 | 0.91 | S1PR3 (0.40) | CNR2CNR1S1PR3P2RX3LIPG | |
| SCHEMBL31203437 | 0.90 | CNR2 (0.43) | CNR2CNR1 | |
| SCHEMBL21485567 | 0.86 | S1PR3 (0.41) | CNR2CNR1S1PR3P2RX3LIPG | |
| SCHEMBL24992157 | 0.85 | CNR1 (0.40) | CNR2CNR1S1PR3HRH3 | |
| SCHEMBL31203159 | 0.85 | CNR2 (0.40) | CNR2CNR1 | |
| SCHEMBL21458130 | 0.85 | PTGER4 (0.39) | CNR2CNR1S1PR3HRH3 | |
| SCHEMBL21485549 | 0.85 | CNR1 (0.41) | CNR2CNR1S1PR3HRH3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3781550-B1 | BICYCLIC CARBOXAMIDES AND METHODS OF USE THEREOF | TEMPEST THERAPEUTICS INC (US) | 2024-10-30 | — | — | EP | claimed |